Literature DB >> 27729418

Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty.

Takashi Kawakami1, Aiko Ogawa1, Katsumasa Miyaji1, Hiroki Mizoguchi1, Hiroto Shimokawahara1, Takanori Naito1, Takashi Oka1, Kei Yunoki1, Mitsuru Munemasa1, Hiromi Matsubara2.   

Abstract

BACKGROUND: Balloon pulmonary angioplasty (BPA) is an alternative therapy for patients with chronic thromboembolic pulmonary hypertension who are ineligible for standard therapy, pulmonary endarterectomy. Although there are several classifications of vascular lesions, these classifications are based on the features of the specimen removed during pulmonary endarterectomy. Because organized thrombi are not removed during balloon pulmonary angioplasty, we attempted to establish a new classification of vascular lesions based on pulmonary angiographic images. We evaluated the success and complication rate of BPA in accordance with the location and morphology of thromboembolic lesions. METHODS AND
RESULTS: We reviewed 500 consecutive procedures (1936 lesions) of BPA in 97 patients with chronic thromboembolic pulmonary hypertension and investigated the outcomes of BPA based on the lesion distribution and the angiographic characteristics of the thromboembolic lesions, as follows: type A, ring-like stenosis lesion; type B, web lesion; type C, subtotal lesion; type D, total occlusion lesion, and type E, tortuous lesion. The success rate was higher, and the complication rate was lower in ring-like stenosis and web lesions. The total occlusion lesions had the lowest success rate. Tortuous lesions were associated with a high complication rate and should be treated only by operators with extensive experience with BPA.
CONCLUSIONS: We modified the previous angiographic classification and established a new classification for each vascular lesion. We clarified that the outcome and complication rate of the BPA are highly dependent on the lesion characteristics.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  angiography; angioplasty; arterial pressure; coronary artery disease; hypertension, pulmonary

Mesh:

Year:  2016        PMID: 27729418     DOI: 10.1161/CIRCINTERVENTIONS.115.003318

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  25 in total

Review 1.  Imaging of Chronic Thromboembolic Disease.

Authors:  Adina Haramati; Linda B Haramati
Journal:  Lung       Date:  2020-03-12       Impact factor: 2.584

2.  Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension.

Authors:  Muhammad Shahzeb Khan; Emaan Amin; Muhammad Mustafa Memon; Naser Yamani; Tariq Jamal Siddiqi; Safi U Khan; Mohammad Hassan Murad; Farouk Mookadam; Vincent M Figueredo; Rami Doukky; Raymond L Benza; Richard A Krasuski
Journal:  Int J Cardiol       Date:  2019-02-23       Impact factor: 4.164

Review 3.  Balloon Pulmonary Angioplasty as a Treatment in Chronic Thromboembolic Pulmonary Hypertension: Past, Present, and Future.

Authors:  Panagiotis Karyofyllis; Eftychia Demerouti; Varvara Papadopoulou; Vassilis Voudris; Hiromi Matsubara
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-02-13

4.  Catheter-Based Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Jane A Leopold
Journal:  Circ Cardiovasc Interv       Date:  2016-10       Impact factor: 6.546

5.  Increasing mixed venous oxygen saturation is a predictor of improved renal function after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Sarasa Isobe; Yuji Itabashi; Takashi Kawakami; Masaharu Kataoka; Shun Kohsaka; Toshimitsu Tsugu; Mai Kimura; Mitsuaki Sawano; Toshiomi Katsuki; Takashi Kohno; Jin Endo; Mitsushige Murata; Keiichi Fukuda
Journal:  Heart Vessels       Date:  2018-11-01       Impact factor: 2.037

Review 6.  Balloon Pulmonary Angioplasty in Patients With Thromboembolic Pulmonary Hypertension.

Authors:  Panagiotis Karyofyllis; Varvara Papadopoulou; Vassilis Voudris; Hiromi Matsubara
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-24

7.  C-Arm computed tomography (CACT)-guided balloon pulmonary angioplasty (BPA): Evaluation of patient safety and peri- and post-procedural complications.

Authors:  Sabine K Maschke; Jan B Hinrichs; Julius Renne; Thomas Werncke; Hinrich M B Winther; Kristina I Ringe; Karen M Olsson; Marius M Hoeper; Frank K Wacker; Bernhard C Meyer
Journal:  Eur Radiol       Date:  2018-09-12       Impact factor: 5.315

Review 8.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Amanda Lloji; Urvashi Hooda; Jayakumar Sreenivasan; Ramin Malekan; Wilbert S Aronow; Gregg M Lanier
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

Review 9.  Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Authors:  Kyoko Hirakawa; Eiichiro Yamamoto; Seiji Takashio; Shinsuke Hanatani; Satoshi Araki; Satoru Suzuki; Koichi Kaikita; Kenichi Matsushita; Takeshi Ogo; Kenichi Tsujita
Journal:  Cardiovasc Interv Ther       Date:  2021-04-29

10.  Systematic Staged Percutaneous Balloon Pulmonary Angioplasty in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Kazuhiro Dan; Akira Shionoda; Hiromi Matsubara
Journal:  Arq Bras Cardiol       Date:  2021-02       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.